Skip to content

Comparison of lung function and pulmonary complications after natural orifice specimen extraction surgery and conventional laparoscopic surgery in rectal cancer patients

Comparison of lung function and pulmonary complications after natural orifice specimen extraction surgery and conventional laparoscopic surgery in rectal cancer patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072585
Enrollment
Unknown
Registered
2023-06-19
Start date
2023-06-19
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rectal cancer

Interventions

treatment group:natural orifice specimen extraction surgery

Sponsors

Shanghai East Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The indications included the following criteria: elective surgery, BMI= (30 kg/m2), aged 18-75 years, tumors located within 15 cm from the anal verge, American Society of Anesthesiologists (ASA) class I-III, no known relevant allergies, no past history of abdominal or thoracic surgery; no coincident procedures.

Exclusion criteria

Exclusion criteria: The exclusion criteria were: massive tumor(> 7 cm), high BMI (> 30 kg/m2), ASA class > III, locally advanced tumor, synchronous primary tumors, metastatic disease, evidence for multiple disease sites, inability to fully mobilize preoperatively (eg, neurological or musculoskeletal diseases), acute bowel obstruction or perforation, anal stenosis, history of neoadjuvant chemoradiotherapy , emergency or agent surgery, additional surgery besides rectal resection. Patients who received low laparoscopic resection with ileostomy, converted to Hartmanns , radical abdominoperineal resection(APR) or open procedure were excluded from this study. Besides, patients with current or previous pulmonary diseases and those suffered from severe diseases, such as cardiovascular diseases, myocardial infarction, or cerebrovascular diseases were also excluded, to avoid the possible influence of previous pulmonary disease on the study results.

Design outcomes

Primary

MeasureTime frame
lung function(FEV1?FVC?VC?PEF?MVV?TV?RV?TLC?FRC?IRV?ERV);pulmonary complications;

Secondary

MeasureTime frame
gastrointestinal recovery time(time to first flatus?defection?feeding);pain assessment;Quality of life assessment;

Countries

China

Contacts

Public ContactZhuqing Zhou

Shanghai East Hospital

zzq2421989@163.com+86 189 1730 4065

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026